相当的恒定剂量速率作为所有光束时间结构中FLASH的统一剂量速率概念
Per Rugaard Poulsen1,2, Brita Singers Sørensen1,2,3, Line Kristensen1,2,3
1Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
Medical physics
|December 15, 2025
概括
一个新的生物基础的剂量速率概念,相当于恒定剂量速率 ( eq,const),可以直接比较FLASH效应在不同的光束模式. 这个概念准确地预测了放射生物学的结果,例如小鼠的皮肤毒性.
科学领域:
- 医学物理 医学物理
- 辐射瘤学 辐射瘤学
- 放射生物学的放射生物学
背景情况:
- 闪光效应与不同的光束时间结构 (脉冲电子,笔光束扫描质子) 有显著差异.
- 由于这些结构差异,对实验FLASH数据的直接比较具有挑战性.
- 为了进行一致的FLASH效应分析,需要一个统一的,基于生物学的剂量速率概念.
研究的目的:
- 定义和开发一个对等常量剂量速率 ( eq,const) 的数学框架.
- 为了研究 eq,const跨越各种光束时间结构.
- 为了建立一个比较FLASH节约效应的基础,无论交付方式如何.
主要方法:
- 使用现象学氧气增强比率 (OER) 的加权剂量模型来节省FLASH.
- 开发了分析方程来计算 eq,const 对于零碎的恒定剂量速率.
- 系统地表征 eq,const用于脉冲束和质子笔束扫描 (PBS).
主要成果:
- 对于脉冲光束, eq,const 的近似值为n/(n+1) ⋅
- eq,const值与PBS参数有显著差异 (例如,没有重新涂料的155Gy/s,分发的7.7Gy/s).
- 计算的
结论:
- 相当的恒定剂量速率 ( eq,const) 是一种普遍适用的,有生物学基础的概念.
- 这一概念使FLASH剂量速率在不同的光束时间结构中可以进行直接比较.
- 它为了解FLASH放射生物学和优化治疗提供了一个强大的指标.
相关概念视频
Biological Effects of Radiation
17.5K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
17.5K
Dose Size and Dosing Frequency: Determination Methods
250
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
250
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
198
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
198
Rational Dosage Regimen: Maintenance Dose and Loading Dose
5.2K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.2K
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
229
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
229
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
192
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
192


